Pierre Duvillard
Overview
Explore the profile of Pierre Duvillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
1958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hadoux J, Rey A, Duvillard P, Lhomme C, Balleyguier C, Haie-Meder C, et al.
Int J Gynecol Cancer
. 2015 Jan;
25(2):296-302.
PMID: 25581897
Objective: Uterine leiomyosarcoma (ULMS) is a rare gynecologic malignancy characterized by a poor prognosis due to a high rate of local and metastatic recurrences. Chemotherapy with doxorubicin or ifosfamide or...
12.
Leary A, Petrella M, Pautier P, Duvillard P, Uzan C, Tazi Y, et al.
Gynecol Oncol
. 2013 Nov;
132(1):23-7.
PMID: 24219980
Background: Most borderline ovarian tumors (BOTs) are cured with surgery. However BOTs with invasive implants have a poor prognosis with a mortality of 20-40%. The benefit of adjuvant chemotherapy (CT)...
13.
Touboul C, Bentivegna E, Uzan C, Gouy S, Pautier P, Lhomme C, et al.
Curr Oncol Rep
. 2013 Nov;
15(6):559-65.
PMID: 24190831
Lymph node status is a major prognostic factor in endometrial cancer (EC). Sentinel lymph node (SLN) biopsy has been reported in EC for more than 15 years but has not...
14.
Hadoux J, Morice P, Lhomme C, Duvillard P, Balleyguier C, Haie-Meder C, et al.
Bull Cancer
. 2013 Sep;
100(9):903-15.
PMID: 24004576
Uterine leiomyosarcoma is a rare disease with a poor prognosis. The rarity of this tumor needs a specialized management in tertiary reference centers in order to provide patients with optimal...
15.
Gouy S, Uzan C, Pautier P, Lhomme C, Duvillard P, Morice P
Eur J Obstet Gynecol Reprod Biol
. 2013 Aug;
170(2):464-7.
PMID: 23915762
Objectives: To assess the efficacy and morbidity of cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) for relapsed ovarian granulosa cell tumors (OGCT). Study Design: Between 2007 and 2009,...
16.
Velayoudom-Cephise F, Duvillard P, Foucan L, Hadoux J, Chougnet C, Leboulleux S, et al.
Endocr Relat Cancer
. 2013 Jul;
20(5):649-57.
PMID: 23845449
The new WHO classification of gastroenteropancreatic (GEP) neuroendocrine tumors (NET) implies that G3 neoplasms with mitotic index >20 and/or Ki67 index >20% are neuroendocrine carcinomas (NEC), described as poorly differentiated,...
17.
Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy
Malouf G, Lhomme C, Duvillard P, Morice P, Haie-Meder C, Pautier P
Int J Gynaecol Obstet
. 2013 Apr;
122(1):57-61.
PMID: 23597861
Objective: To describe the natural history, prognostic factors, and optimal treatment modalities of undifferentiated endometrial sarcoma (UES). Methods: A retrospective review was conducted of 30 patients with UES treated at...
18.
Lataifeh I, Al-Hussaini M, Uzan C, Jaradat I, Duvillard P, Morice P
Int J Gynecol Cancer
. 2013 Apr;
23(5):900-5.
PMID: 23552807
Objective: To investigate the clinicopathologic features, the management, and the outcome of villoglandular papillary adenocarcinoma (VGPA) of the uterine cervix. Methods: A retrospective review of patients' clinical characteristics, pathology, and...
19.
Chougnet C, Leboulleux S, Caramella C, Lumbroso J, Borget I, Deandreis D, et al.
Endocr Relat Cancer
. 2013 Feb;
20(2):229-39.
PMID: 23404855
Recent studies suggest that the somatostatin receptor scintigraphy (SRS) grade of uptake is a predictor of response to peptide receptor radionuclide therapy (PRRT). To identify and characterize patients with well-differentiated...
20.
Elias D, Duchalais E, Dartigues P, Duvillard P, Poirot C, Goere D
Ann Surg Oncol
. 2013 Feb;
20(6):1837-42.
PMID: 23370670
Objective: To appreciate if the ovaries can be preserved in selected young women with peritoneal carcinomatosis (PC). Background: The traditional rule is to resect the ovaries systematically when PC is...